Breuer, J. and Nachtnebel, A. (2014): Horizon Scanning in Oncology: Results of the 20th Prioritisation – 3rd quarter 2014. HSO: 20th Prioritisation.
|PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader|
For the 20th prioritisation (September 2014), 7 were filtered out of 145 identified drugs and were sent to prioritisation. Of these, 4 drugs were ranked as 'highly relevant' by the expert panel, 3 as 'relevant' and none as 'not relevant'. For 'highly relevant' drugs, further information including, for example, abstracts of phase III studies and licensing status is contained in this document.
|Item Type:||DSD: Horizon Scanning in Oncology|
|Subjects:||WB Practice of medicine > WB 300-962 Therapeutics|
QZ Pathology > QZ 200-380 Neoplasms.Cysts
|Series Name:||HSO: 20th Prioritisation|
|Deposited on:||27 Oct 2014 14:05|
|Last Modified:||10 Jan 2017 19:12|
Repository Staff Only: item control page